title: Case of relapsed CD20(+) mixed-cellularity Hodgkin disease treated with sequential rituximab and radiotherapy.
authors.forename: Michalis V
authors.initials: MV
authors.lastname: Karamouzis
authors.forename: Nikiforos
authors.initials: N
authors.lastname: Apostolikas
authors.forename: Chara
authors.initials: C
authors.lastname: Georganta
authors.forename: Giorgos
authors.initials: G
authors.lastname: Lainakis
authors.forename: Kostas
authors.initials: K
authors.lastname: Kandylis
authors.forename: Gerasimos
authors.initials: G
authors.lastname: Rigatos
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20 / Q000276:immunology*; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D012008:Recurrence; D016539:Reed-Sternberg Cells / Q000276:immunology*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D018951:Antigens, CD20; D000970:Antineoplastic Agents; D000069283:Rituximab